2022 年 68 巻 4 号 p. 393-397
In this article, we report the case of a patient with unresectable stage III squamous cell lung carcinoma who developed immune-related adverse events in the gastrointestinal tract following the administration of immune checkpoint inhibitors. The patient developed severe acute respiratory syndrome coronavirus 2 pneumonia and cytomegalovirus gastritis during immunosuppressive therapy for an immune-related adverse event. Cytomegalovirus infection was managed with the administration of ganciclovir.